334 Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment.
http://www.sciencemag.org/content/342/6161/967.abstract
333 Bone morphogenetic protein-9 inhibits lymphatic vessel formation via activin receptor-like kinase 1 during development and cancer progression.
http://www.pnas.org/content/110/47/18940.abstract
332 Photoswitchable nanoparticles for in vivo cancer chemotherapy.
http://www.pnas.org/content/110/47/19048.abstract
331 miRNA and mRNA cancer signatures determined by analysis of expression levels in large cohorts of patients.
http://www.pnas.org/content/110/47/19160.abstract
330 mTOR plays critical roles in pancreatic cancer stem cells through specific and stemness-related functions.
http://www.nature.com/srep/2013/131115/srep03230/full/srep03230.html
329 DIM (3,3′-diindolylmethane) confers protection against ionizing radiation by a unique mechanism.
http://www.pnas.org/content/110/46/18650.abstract
328 Enhancing tumor cell response to chemotherapy through nanoparticle-mediated codelivery of siRNA and cisplatin prodrug.
http://www.pnas.org/content/110/46/18638.abstract
327 Combining two strategies to improve perfusion and drug delivery in solid tumors.
http://www.pnas.org/content/110/46/18632.abstract
326 Dynamic palmitoylation links cytosol-membrane shuttling of acyl-protein thioesterase-1 and acyl-protein thioesterase-2 with that of proto-oncogene H-ras product and growth-associated protein-43.
http://www.ncbi.nlm.nih.gov/pubmed/23396970
325 IntOGen-mutations is a discovery tool for cancer researchers to find driver mutations in genes and pathways.
http://www.nature.com/nmeth/journal/v10/n11/abs/nmeth.2642.html
324 A new cloning and expression system yields and validates TCRs from blood lymphocytes of patients with cancer within 10 days.
http://www.nature.com/nm/journal/v19/n11/abs/nm.3358.html
323 Coordinate activation of Shh and PI3K signaling in PTEN-deficient glioblastoma: new therapeutic opportunities.
http://www.nature.com/nm/journal/v19/n11/abs/nm.3328.html
322 The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex.
http://www.nature.com/ng/journal/v45/n11/abs/ng.2771.html
321 Monoallelic loss of tumor suppressor GRIM-19 promotes tumorigenesis in mice.
http://www.pnas.org/content/110/45/E4213.abstract
320 Tumour-on-a-chip provides an optical window into nanoparticle tissue transport.
http://www.nature.com/ncomms/2013/131031/ncomms3718/full/ncomms3718.html
319 Bispecific small molecule–antibody conjugate targeting prostate cancer.
http://www.pnas.org/content/110/44/17796.abstract
318 Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans.
http://www.pnas.org/content/110/44/17945.abstract
317 Aging predisposes to acute inflammatory induced pathology after tumor immunotherapy.
http://jem.rupress.org/content/210/11/2223.abstract
316 Switch of glycolysis to gluconeogenesis by dexamethasone for treatment of hepatocarcinoma.
http://www.nature.com/ncomms/2013/131022/ncomms3508/full/ncomms3508.html
315 Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy.
http://www.nature.com/nbt/journal/v31/n10/full/nbt.2678.html
|
